Pilot Trial of Low-Dose Colchicine in CKD Aims to Improve Vascular and Bone Outcomes
A pilot trial is assessing the efficacy of low-dose colchicine in improving vascular disease and biomarkers in CKD stage 3 patients.
Indication
Clinical and regulatory intelligence for Chronic Kidney Disease with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.